Navigation Links
Kidney disease worsens in a fourth of African-Americans despite therapy for hypertension
Date:5/5/2008

cluded in 2001 that an ACE inhibitor medication protected the kidneys better than two other classes of blood pressure drugs. During the Cohort Study, nearly 9 out of 10 participants were taking an ACE inhibitor or an angiotensin receptor blocking drug, and average blood pressure was 133/78 mmHg, close to national guidelines for high blood pressure in people with chronic kidney disease.

Uncontrolled high blood pressure, an increase in the number of people with diabetes, and the aging of the U.S. population means more people than ever are getting and living with kidney problems. About 13 percent of the U.S. population, up from 10 percent in 1994, now have chronic kidney disease. And in 2005, more than 485,000 people were on chronic dialysis or had a kidney transplant for kidney failure, costing Medicare, private insurers and patients $32 billion.


'/>"/>

Contact: Mary Harris
niddkmedia@mail.nih.gov
301-496-3583
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game(TM)
2. 3 Women Suffer Kidney Failure After Derriere Injections
3. Bioartificial Kidney Cuts Death Risk, Improves Outcomes
4. Kidney Care Community Applauds National Taxpayers Unions Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal Common Sense Coverage Reform
5. Cutting Phosphate May Protect Kidney Patients From Heart Trouble
6. Muscle Mass May Not Explain High Creatinine in Black Kidney Patients
7. Readily available treatment could help prevent heart disease in kidney patients
8. Study Points to New Treatments for Polycystic Kidney Disease
9. Raloxifene Safe for Women With Decreased Kidney Function
10. Kidney cancer deaths show overall decrease in Europe
11. Diplomat Specialty Pharmacy Hires National Accounts Director To Expand Kidney Disease Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Newswire/ -- New research at West Virginia Univer...obacco product aimed at young adults is catching o..., Camel Snus - touted as a socially acceptable way... levels of nicotine. , , "Camel Snus contai...said Bruce Adkins of the state Division of Tobacco...
(Date:11/21/2008)...eral membership of the Medical,Advertising Hall o...eir Annual,Awards Dinner to be held February 10, ...Achievement Award will also be given. , The...of Fame are: , Ronald Pantello, who began his a...ler & Hennessey. In 1980 he left Sudler & ...
(Date:11/21/2008)...s production of neural stem cells , , FR...n mice, exercise appears to reverse the decline in...ith aging, Taiwanese researchers report. , This...stave off aging appears to be due to exercise,s ab... for the production of new brain cells. , "As ...
(Date:11/21/2008)...-- A prestigious group of physicians, nurses, and ...sburg, VA on March 27-29, 2009 at the Williamsburg... cutting-edge therapeutic protocols, novel diagnos...hat impact patient care. The full program, faculty...vailable at www.bioconferences.com/wh , , ...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:Exercise Keeps the Brain Young 2Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2
...lth Minister Anbumani Ramadoss, has called a meeti...discuss the measures to be taken to control the mo...nisters of Andhra Pradesh, Tamil Nadu, Kerala, Kar...t, Maharashtra, Goa and Delhi are expected to atte...
...,000 infants die each year in the Asia-Pacific reg...pert told a regional conference on Wednesday . T...in Eastern and Southeastern Asia whose deaths are ...le and as imminently correctable as sub-optimal br...
...tish climate change official said Wednesday there ...de (CO2) emissions after a new report suggested t...est polluter. In an interview to the British Broa...ton of Britain's Foreign Office was quoted as sayi...
...s offered help to India in tackling its severe wat...water but also in areas like waste water treatment... principles, approach and technologies are applica...ef Dreizen, deputy commissioner of water and the h...
Other Medicine News:Health News:Decline in Breastfeeding Linked to Child Deaths in Asia: UNICEF 2Health News:China Cannot Be Blamed for Rising CO2 Emissions: Britain Official 2Health News:Israel Offers Help to India in Tackling Water Scarcity 2
(Date:11/21/2008)...ND OAKS, Calif., Nov. 21 ... European Committee for Medicinal,Products for Hu...mending,marketing authorisation for Nplate(TM) (r... recommends Nplate for adult chronic immune (idiop...sed patients who are refractory to,other treatmen...
(Date:11/20/2008)... HILL, N.J., Nov. 20 New Jersey Am...ter advisory for its customers in the following m...nties: , , Middlesex County , , , ..., Piscataway , South Plainfield , ... Bound Brook , Bridgewater , Gr...
(Date:11/20/2008)...ILLE, Calif., Nov. 20 Bi...ny will present results from the Phase 1B,clinica...metastatic breast,cancer, BZL101, at the Society ...nference in Atlanta, Georgia. The Company,s oral ...ct and will be presented as a part of the Best of ...
(Date:11/20/2008)...OMSO, Norway, November 20 The Scan...pharma has announced results of studies on its,le...CAAC in Washington, DC,the studies showed that t...bacteriocidal effect, significantly better towards...pyogenes than marketed gold standard drugs. In,ad...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New study of targeted therapies for breast cancer model for global clinical trials 13096 1New study of targeted therapies for breast cancer model for global clinical trials 13096 2New study of targeted therapies for breast cancer model for global clinical trials 13096 3New study of targeted therapies for breast cancer model for global clinical trials 13096 4Abraham Lincoln Presenter to Speak in Tulsa This Saturday 13094 1Test for Life Campaign Screens Record Number of DC Residents for HIV AIDS 1444 1Test for Life Campaign Screens Record Number of DC Residents for HIV AIDS 1444 2Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System 2352 1Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System 2352 2
...OMO), Italy--(BUSINESS WIRE)--Apr 13, 2007 -,Genti...orted that,its lead investigational product, Defib...tions at the American Association for Cancer,Resea...Angeles,Conference Center in Los Angeles, Californ...2007, from 1:00 p.m. to 5:00 p.m. (Pacific,Time), ...
...., April 13, 2007 /PRNewswire/ -- Mersana, a,cance...ts of,preclinical studies with its lead product ca...s at the 2007 Annual Meeting of the,American Assoc...l,14-18th in Los Angeles, CA. Full text of the abs... <a target="_blank" href=,"http://www.aacr.org/">h...
Other Medicine Technology:Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting 2Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting 3Gentium's Defibrotide Highlighted in Two Poster Presentations at,American Association for Cancer Research Annual Meeting 4Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2
..., real-time thermal cycler used for identifying DN...ing much of the testing process, and making each r...fastest, easiest to use, and most flexible system ... accurate and consistent test results in as little...
...ection System is a high-throughput real-time PCR s...quences. An Automation Accessory combined with 384...lly suited to meet the high-throughput requirement...ns include gene expression quantitation and the de...
Sealing Mat for 384-well, Square Well Plates Available Sterile
Sealing Mat for 384-well PCR Plate, Natural
Medicine Products: